| Host: |
Goat |
| Applications: |
Pep-ELISA/WB/IF |
| Reactivity: |
Human/Mouse/Rat/Pig/Cow |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-UBE2L3 (C-Term) is suitable for use in ELISA, Western Blot and Immunofluorescence research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:128000.WB: Approx 18kDa band observed in lysates of cell lines HeLa HEK293, HepG2 and Jurkat and also in lysates of Human, Mouse and Rat Heart, Skeletal Muscle and Testis and of Pig Heart (calcu |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Gene Symbol: |
UBE2L3 |
| Gene ID: |
7332 |
| Uniprot ID: |
UB2L3_HUMAN |
| Immunogen Region: |
C-Term |
| Accession Number: |
NP_003338.1 |
| Immunogen Sequence: |
EFTKKYGEKRPVD |
| Post Translational Modifications | Ubiquitinated. The alteration of UBE2L3 protein levels during the S-phase of the cell cycle is due to ubiquitin-dependent proteasomal degradation. Autoubiquitinated in vitro. |
| Function | Ubiquitin-conjugating enzyme E2 that specifically acts with HECT-type and RBR family E3 ubiquitin-protein ligases. Does not function with most RING-containing E3 ubiquitin-protein ligases because it lacks intrinsic E3-independent reactivity with lysine.in contrast, it has activity with the RBR family E3 enzymes, such as PRKN, RNF31 and ARIH1, that function like RING-HECT hybrids. Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Mediates ubiquitination by the CUL9-RBX1 complex. In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis. |
| Protein Name | Ubiquitin-Conjugating Enzyme E2 L3E2 Ubiquitin-Conjugating Enzyme L3L-UbcUbch7Ubiquitin Carrier Protein L3Ubiquitin-Conjugating Enzyme E2-F1Ubiquitin-Protein Ligase L3 |
| Database Links | Reactome: R-HSA-5205685Reactome: R-HSA-5357905Reactome: R-HSA-5675482Reactome: R-HSA-8866652Reactome: R-HSA-8866654Reactome: R-HSA-983168 |
| Cellular Localisation | NucleusCytoplasm |
| Alternative Antibody Names | Anti-Ubiquitin-Conjugating Enzyme E2 L3 antibodyAnti-E2 Ubiquitin-Conjugating Enzyme L3 antibodyAnti-L-Ubc antibodyAnti-Ubch7 antibodyAnti-Ubiquitin Carrier Protein L3 antibodyAnti-Ubiquitin-Conjugating Enzyme E2-F1 antibodyAnti-Ubiquitin-Protein Ligase L3 antibodyAnti-UBE2L3 antibodyAnti-UBCE7 antibodyAnti-UBCH7 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
